Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients (Q43041131)

12 November 2017

Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients (English)

1 reference

12 November 2017

1 reference

1 reference

1 reference

3

1 reference

12 November 2017

Johan Westin

1

1 reference

12 November 2017

Hans Nordlinder

series ordinal

2

1 reference

12 November 2017

Gunnar Norkrans

series ordinal

4

1 reference

12 November 2017

Rune Wejstål

series ordinal

5

1 reference

12 November 2017

1 December 2002

1 reference

12 November 2017

Journal of Hepatology

1 reference

12 November 2017

37

1 reference

12 November 2017

837-842

1 reference

12 November 2017

6

1 reference

The pathology of hepatitis C

12 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900299-4

7 January 2021

The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900299-4

7 January 2021

Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900299-4

7 January 2021

Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900299-4

7 January 2021

Hepatitis C virus core protein induces hepatic steatosis in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900299-4

7 January 2021

Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900299-4

7 January 2021

Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900299-4

7 January 2021

Hepatic steatosis in chronic hepatitis C virus infection: prevalence and clinical correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900299-4

7 January 2021

Host- and disease-specific factors affecting steatosis in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900299-4

7 January 2021

Liver steatosis and chronic hepatitis C: a spurious association?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900299-4

7 January 2021

Chronic hepatitis C and superimposed nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900299-4

7 January 2021

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900299-4

7 January 2021

Histological grading and staging of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900299-4

7 January 2021

Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900299-4

7 January 2021

Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers: epidemiological applications

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900299-4

7 January 2021

Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900299-4

7 January 2021

Liver steatosis in chronic hepatitis C: a morphological sign suggesting infection with HCV genotype 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900299-4

7 January 2021

Hepatic steatosis: a specific sign of hepatitis C reinfection after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900299-4

7 January 2021

Body composition and hepatic steatosis as precursors of fibrosis in chronic hepatitis C patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900299-4

7 January 2021

Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900299-4

7 January 2021

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900299-4

7 January 2021

Steatosis and intrahepatic hepatitis C virus in chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900299-4

7 January 2021

Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900299-4

7 January 2021

Progression of fibrosis in untreated patients with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900299-4

7 January 2021

Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900299-4

7 January 2021

Chronic hepatitis C in Sweden: genotype distribution over time in different epidemiological settings

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900299-4

7 January 2021

Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2802%2900299-4

7 January 2021

10.1016/S0168-8278(02)00299-4

Identifiers

DOI

1 reference

12 November 2017

1 reference